Company
United StatesPublic company, NASDAQ: AMGNAmgen, Incorporated (NASDAQ: AMGN), Longmont, CO – FDA Inspections
Inspection records and compliance data for Amgen, Incorporated in Longmont, Colorado. 4 FDA inspections on record, 1 warning letter, last inspected February 11, 2015. Publicly traded as NASDAQ: AMGN.
Company Profile
This profile covers Amgen, Incorporated based in Longmont, Colorado, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 4
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 1
First inspected September 3, 2010. Last inspected February 11, 2015.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 11, 2015 | VAI | Human Drugs · Drug Quality Assurance | 913647 |
| March 29, 2013 | VAI | Human Drugs · Drug Quality Assurance | 824931 |
| January 6, 2012 | VAI | Human Drugs · Drug Quality Assurance | 756905 |
| September 3, 2010 | VAI | Human Drugs · Drug Quality Assurance | 680729 |
FDA documents
Warning Letters (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Amgen, Incorporated
Stock ticker
AMGN
Exchange
NASDAQ
Share price
$467.06
Market cap
$252.6B
Price as of
November 13, 2026
FEI Number
3002892484
Address
4000 Nelson Rd, Longmont, Colorado 80503, United States
Country
United States
ID: 0b436db9-6f14-47b3-9f8b-fe12ddd01d13